Journal of Neuro Oncology

• 

  Publication Venue For

  • Fertility treatment is associated with multiple meningiomas and younger age at diagnosis..  143:137-144. 2019
  • Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients.  125:307-315. 2015
  • Nanoshell-mediated photothermal therapy improves survival in a murine glioma model..  104:55-63. 2011
  • Erratum: Convection-enhanced delivery of free gadolinium with the recombinant immunotoxin MR1-1 (Journal of Neuro-Oncology DOI 10.1007/s11060-009-0046-7).  98:9. 2010
  • Cryptococcal meningitis in patients with glioma: a report of two cases..  89:51-53. 2008
  • Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines..  86:165-172. 2008
  • Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas..  83:53-60. 2007
  • Intelligence and adaptive function in children diagnosed with brain tumour during infancy..  80:295-303. 2006
  • Primary spinal yolk sac tumor with brain metastasis: case report and review of the literature..  78:249-253. 2006
  • Somnolence syndrome after focal radiation therapy to the pineal region: case report and review of the literature..  78:153-156. 2006
  • A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group..  77:193-198. 2006
  • Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma..  77:207-212. 2006
  • Central neurocytoma: a review..  66:377-384. 2004
  • The evolving role of stereotactic radiosurgery and stereotactic radiation therapy for patients with spine tumors..  69:319-334. 2004
  • Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors..  65:27-35. 2003
  • The history, evolution, and clinical use of dendritic cell-based immunization strategies in the therapy of brain tumors..  64:161-176. 2003
  • Current options for the treatment of neoplastic meningitis..  60:79-88. 2002
  • Surgical approaches to pineal region tumors..  54:287-299. 2001
  • Evaluation of pre-radiotherapy cyclophosphamide in patients with newly diagnosed glioblastoma multiforme. Writing Committee for The Brain Tumor Center at Duke..  46:151-156. 2000
  • Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study..  43:43-47. 1999
  • Expression of TGFalpha in meningiomas..  45:127-134. 1999
  • Intrathecal busulfan treatment of human neoplastic meningitis in athymic nude rats..  44:233-241. 1999
  • Central nervous system atypical teratoid tumor/rhabdoid tumor: response to intensive therapy and review of the literature..  40:265-275. 1998
  • Acute leukemia following treatment of malignant glioma..  40:39-46. 1998
  • Ependymomas: MIB-1 proliferation index and survival..  40:51-57. 1998
  • Monoclonal antibodies to growth factors and growth factor receptors: their diagnostic and therapeutic potential in brain tumors..  35:259-273. 1997
  • PROMACE-MOPP and intrathecal chemotherapy for CNS lymphomas..  28:25-30. 1996
  • Fabrication and testing of a device capable of reducing the incidence of ventricular shunt promoted metastasis..  27:39-46. 1996
  • Treatment of infants with malignant gliomas: the Pediatric Oncology Group experience..  28:245-256. 1996
  • A phase II study of every other day high-dose ifosfamide in pediatric brain tumors: a Pediatric Oncology Group Study..  25:77-84. 1995
  • Cyclophosphamide therapy of medulloblastoma: from the laboratory to the clinic and back again (and again and again)..  24:103-108. 1995
  • Meta-[131I]iodobenzylguanidine uptake and meta-[211At]astatobenzylguanidine treatment in human medulloblastoma cell lines..  25:9-17. 1995
  • Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report..  24:109-122. 1995
  • Primary central nervous system lymphoma with systemic metastasis: case report and review..  23:207-221. 1995
  • Prognostic implications of chromosome 17p deletions in human medulloblastomas..  24:39-45. 1995
  • Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model..  18:129-138. 1994
  • Multiple fraction-per-day radiotherapy for patients with brain stem tumors..  17:131-138. 1993
  • Pituitary oncocytomas: clinical features, characteristics in cell culture, and treatment recommendations..  16:39-46. 1993
  • Multiple-fraction-per-day external beam radiotherapy for adults with supratentorial malignant gliomas..  14:255-262. 1992
  • Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failure..  12:187-191. 1992
  • Isolation and characterization of microvessels from normal brain and brain tumors..  11:49-55. 1991
  • Medulloblastoma: tumor biological and clinical perspectives..  11:1-15. 1991
  • In memoriam Lucien J. Rubinstein, M.D. (1924-1990)..  9:III-VI. 1990
  • Severe encephalopathy associated with ifosfamide administration in two children with metastatic tumors..  6:29-30. 1988
  • Correlation of neuropathologic findings, computerized tomographic and high-resolution ultrasound scans of canine avian sarcoma virus-induced brain tumors..  4:243-268. 1987
  • Effect of methylprednisolone on radiotherapy of F344 rats with avian sarcoma virus induced gliomas..  4:309-313. 1987
  • The chemotherapy of posterior fossa tumors in childhood..  5:217-229. 1987
  • Treatment of autochthonous rat brain tumors with steroid plus heparin: a brief report..  5:161-162. 1987
  • Summary of the sixth international conference on brain tumor research and therapy.  4:3-4. 1986
  • ACRYLONITRILE NEUROONCOGENESIS IN F344 RATS.  4:94-94. 1986
  • CHARACTERIZATION OF LOCALIZING GLIOMA-REACTIVE MONOCLONAL-ANTIBODIES (MABS).  4:107-107. 1986
  • CHROMOSOMES AND GENE AMPLIFICATION IN MALIGNANT HUMAN GLIOMAS.  4:92-92. 1986
  • COOPERATIVE STUDIES OF CHEMOTHERAPY FOR GLIOMAS AND MEDULLOBLASTOMAS.  4:108-108. 1986
  • Continuous human glioma-derived cell lines UC-11MG and UC-302MG. Morphologic, immunocytochemical and chromosomal characterization..  3:373-385. 1986
  • MOUSE MONOCLONAL-ANTIBODIES TO HUMAN GLIOMA-CELLS.  4:101-101. 1986
  • PROTOONCOGENES AS REGULATORS OF GROWTH AND DIFFERENTIATION.  4:92-92. 1986
  • SYNCHRONIZATION OF HUMAN GLIOMA CELL-LINES WITH HYDROXYUREA.  4:95-95. 1986
  • THE HISTOCHEMICAL-LOCALIZATION OF GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) IN HUMAN CENTRAL-NERVOUS-SYSTEM (CNS) NEOPLASMS BY MONOCLONAL-ANTIBODIES (MCAS).  4:96-96. 1986
  • UTILIZATION OF PURIFIED, RADIOLABELED MONOCLONAL-ANTIBODY FAB FRAGMENTS FOR INVIVO LOCALIZATION IN MALIGNANT GLIOMAS.  4:107-107. 1986
  • Immunohistochemical study of glial fibrillary acidic protein in avian sarcoma virus-induced gliomas in dogs..  3:53-59. 1985
  • Immunolocalization of monoclonal antibody-defined extracellular matrix antigens in human brain tumors..  3:181-186. 1985
  • ANTIGENIC HETEROGENEITY OF HUMAN GLIOMA TISSUE AND CELL-LINES (HGL) DEFINED BY MONOCLONAL-ANTIBODIES (MAS).  2:267-267. 1984
  • CLINICAL-TRIALS OF DIAZIQUONE (AZQ) IN PATIENTS WITH PRIMARY CENTRAL NERVOUS-SYSTEM (CNS) NEOPLASMS.  2:289-289. 1984
  • CORRELATION OF NEUROPATHOLOGIC FINDINGS, COMPUTERIZED TOMOGRAPHIC AND HIGH-RESOLUTION ULTRASOUND SCANS OF CANINE AVIAN-SARCOMA VIRUS-INDUCED BRAIN-TUMORS.  2:272-272. 1984
  • GLUTAMINE REQUIREMENTS OF HUMAN GLIOMA AND MEDULLOBLASTOMA IN CULTURE.  2:264-264. 1984
  • IMMUNOLOCALIZATION OF MONOCLONAL ANTIBODY-DEFINED EXTRACELLULAR-MATRIX COMPONENTS IN MALIGNANT GLIOMAS AND MEDULLOBLASTOMAS.  2:274-274. 1984
  • INTRACEREBRAL TRANSPLANTATION OF D-54 MG HUMAN GLIOMA LINE IN IMMUNOSUPPRESSED RATS.  2:268-268. 1984
  • KARYOTYPIC AND HISTOLOGIC ANALYSIS OF MALIGNANT HUMAN GLIOMAS (MHG).  2:264-264. 1984
  • THE EFFECTS OF DEXAMETHASONE ON BLOOD-FLOW AND CAPILLARY-PERMEABILITY IN AN EXPERIMENTAL BRAIN-TUMOR.  2:274-274. 1984
  • THE USE OF HUMAN MEDULLOBLASTOMA MODELS TO DESIGN RATIONAL THERAPY.  2:286-286. 1984
  • Growth, morphology, and serial transplantation of anaplastic human gliomas in athymic mice..  1:5-14. 1983